Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

15.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
15.3K
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

17.9K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Selecting Candidates for Genetic Therapy: A Patient-Centered Framework.

Current gene therapy·2026
Same author

Advancing training on genetic therapies: a multi-specialty survey highlighting the role of medical geneticists.

European journal of human genetics : EJHG·2026
Same author

Survey on new technologies and precision medicine to advance healthcare.

Journal of community genetics·2026
Same author

The relationship between interfacial overlap and functional divergence in the yeast protein-protein interaction network.

Structure (London, England : 1993)·2025
Same author

Graph Representation Learning for the Prediction of Medication Usage in the UK Biobank Based on Pharmacogenetic Variants.

Bioengineering (Basel, Switzerland)·2025
Same author

Mutation Edgotype Drives Fitness Effect in Human.

Frontiers in bioinformatics·2022
Same journal

Correction: Komatsu et al. Three-Dimensional Visualization and Detection of the Pulmonary Venous-Left Atrium Connection Using Artificial Intelligence in Fetal Cardiac Ultrasound Screening. <i>Bioengineering</i> 2026, <i>13</i>, 100.

Bioengineering (Basel, Switzerland)·2026
Same journal

Comparison of CO<sub>2</sub> Laser and Microdebrider in the Surgical Treatment of Pediatric Recurrent Respiratory Papillomatosis: A Retrospective Analysis.

Bioengineering (Basel, Switzerland)·2026
Same journal

Toward More Translational Tumor Models: Breast dECM-Based 3D Systems Capture Native Microenvironmental Cues.

Bioengineering (Basel, Switzerland)·2026
Same journal

Postural Stability Changes During the 4 Phases of the Half Squat: Kinematics Profile of the Center of Pressure and Center of Mass in High-Performance Weightlifters-A Pilot Study.

Bioengineering (Basel, Switzerland)·2026
Same journal

Definite Implant Position as Novel Readout for Effectiveness of Ridge Preservation Indicates to Beneficial Effect of Combined Treatment with Platelet-Rich Fibrin (PRF) and Xenogenic Biomaterial in Bone Regeneration.

Bioengineering (Basel, Switzerland)·2026
Same journal

Trueness and Precision of Intraoral Scanners for 3D-Printed Orthodontic Models with Attachments: An In Vitro Comparative Study.

Bioengineering (Basel, Switzerland)·2026
See all related articles

Related Experiment Video

Updated: Jan 13, 2026

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
06:41

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

14.2K

Disease-Specific Prediction of Missense Variant Pathogenicity with DNA Language Models and Graph Neural Networks.

Mohamed Ghadie1, Sameer Sardaar1, Yannis Trakadis1,2,3

  • 1Research Institute of the McGill University Health Centre (RI-MUHC), Montreal, QC H4A 3J1, Canada.

Bioengineering (Basel, Switzerland)
|October 29, 2025
PubMed
Summary
This summary is machine-generated.

This study introduces a novel machine learning approach to accurately predict the health impact of genetic variants, improving classification of uncertain significance variants for precision medicine.

Keywords:
ClinVardisease-specific variant interpretationgenetic variant pathogenicity predictiongenomic embeddingsgraph convolutional neural network (GCN)machine learning (ML)missense variantsneural network classifiervariants of uncertain significance (VUS)

More Related Videos

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

11.3K
Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
08:04

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Published on: June 6, 2025

1.4K

Related Experiment Videos

Last Updated: Jan 13, 2026

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
06:41

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

14.2K
Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

11.3K
Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
08:04

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Published on: June 6, 2025

1.4K

Area of Science:

  • Genomics
  • Bioinformatics
  • Computational Biology

Background:

  • Accurate prediction of genetic variant impact is crucial for clinical genetics and precision medicine.
  • Many missense variants are currently classified as variants of uncertain significance (VUS), limiting clinical utility.
  • Existing machine learning models have shown variable success in predicting variant pathogenicity.

Purpose of the Study:

  • To develop a novel method for disease-specific prediction of missense variant pathogenicity.
  • To integrate comprehensive biomedical knowledge and genomic sequence data for improved variant interpretation.
  • To reduce the number of variants classified as VUS in clinical settings.

Main Methods:

  • Utilized a knowledge graph with 11 interconnected biomedical entity types.
  • Employed BioBERT for biomedical feature embedding and DNA language models for variant sequence embedding.
  • Implemented a two-stage architecture: graph convolutional neural network followed by a neural network classifier.
  • Trained the model to predict disease-specific variant pathogenicity by identifying edges between variant and disease nodes.

Main Results:

  • Achieved prediction-balanced accuracies up to 85.6% (sensitivity: 90.5%; NPV: 89.8%).
  • Demonstrated the effectiveness of integrating diverse biomedical knowledge and genomic data.
  • Showcased improved classification performance compared to existing methods for missense variants.

Conclusions:

  • The developed approach offers a powerful tool for accurate, disease-specific variant pathogenicity prediction.
  • This method has the potential to significantly aid clinical genetics and advance precision medicine.
  • Future studies can build upon this framework to further refine variant interpretation and clinical decision-making.